Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 46.16% | 18.44% | -98.62% | -643.76% | 77.63% |
Total Depreciation and Amortization | -0.21% | -0.14% | 0.01% | 0.97% | 9.73% |
Total Amortization of Deferred Charges | 20.28% | -49.59% | 3,054.84% | 0.00% | 47.62% |
Total Other Non-Cash Items | -49.87% | -3.51% | 95.90% | 198.35% | -285.29% |
Change in Net Operating Assets | -81.29% | 263.59% | 43.19% | -192.83% | -218.78% |
Cash from Operations | -54.55% | 245.23% | 11.45% | -87.91% | -179.74% |
Capital Expenditure | -693.41% | 84.52% | 10.64% | -21.18% | 68.12% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | 100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 99.09% | -- | -- | -- | -- |
Cash from Investing | 97.96% | -10,711.39% | 10.64% | -21.18% | 99.46% |
Total Debt Issued | -100.00% | 7.89% | -- | -- | -100.00% |
Total Debt Repaid | -- | 100.00% | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -51.42% | -284.40% | 165.29% | -937.48% | 86.31% |
Cash from Financing | -108.32% | 201.15% | 827.50% | -254.38% | -102.02% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -103.94% | 204.83% | 243.26% | -113.01% | -719.64% |